Nursing Considerations for Using Selinexor in Multiple Myeloma

January 03, 2022

An expert from the Tisch Cancer Institute highlights the importance of medication adherence, nausea management, and proper hydration for patients being treated with selinexor for relapsed or refractory multiple myeloma.

Many Patients Are Under-Sedated During End-of-Life Cancer Care

December 31, 2021

David Hui, MD, MSc, from The University of Texas MD Anderson Cancer Center, discusses findings indicating that patients with agitated delirium may be under-sedated, in accordance with their personalized sedation goal.

Clinical Nurse Specialist Explains Meaning and Impact of Implicit Bias on Patients

November 26, 2021

Kathy Burns, MS, APRN-CNS, AGCNS-BC, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of being mindful about one’s implicit bias in the treatment of patients with cancer who have substance use disorders.